BRPI0910534A2 - terapia antiviral - Google Patents

terapia antiviral

Info

Publication number
BRPI0910534A2
BRPI0910534A2 BRPI0910534A BRPI0910534A BRPI0910534A2 BR PI0910534 A2 BRPI0910534 A2 BR PI0910534A2 BR PI0910534 A BRPI0910534 A BR PI0910534A BR PI0910534 A BRPI0910534 A BR PI0910534A BR PI0910534 A2 BRPI0910534 A2 BR PI0910534A2
Authority
BR
Brazil
Prior art keywords
antiviral therapy
antiviral
therapy
Prior art date
Application number
BRPI0910534A
Other languages
English (en)
Inventor
Edward Oakeley
François H T Duong
Magdalena Sarasin-Filipowicz
Markus Heim
Witold Filipowicz
Original Assignee
Novartis Forschungsstiftung
Univ Hospital Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung, Univ Hospital Basel filed Critical Novartis Forschungsstiftung
Publication of BRPI0910534A2 publication Critical patent/BRPI0910534A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0910534A 2008-04-21 2009-04-20 terapia antiviral BRPI0910534A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154878 2008-04-21
PCT/EP2009/054641 WO2009130176A1 (en) 2008-04-21 2009-04-20 Antiviral Therapy

Publications (1)

Publication Number Publication Date
BRPI0910534A2 true BRPI0910534A2 (pt) 2015-09-29

Family

ID=39830378

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910534A BRPI0910534A2 (pt) 2008-04-21 2009-04-20 terapia antiviral

Country Status (16)

Country Link
US (1) US20110117563A1 (pt)
EP (1) EP2271776A1 (pt)
JP (1) JP2011519551A (pt)
KR (1) KR20110014979A (pt)
CN (1) CN102016072A (pt)
AU (1) AU2009240021B2 (pt)
BR (1) BRPI0910534A2 (pt)
CA (1) CA2719078A1 (pt)
IL (1) IL208351A0 (pt)
MA (1) MA32274B1 (pt)
MX (1) MX2010011587A (pt)
NZ (1) NZ588144A (pt)
RU (1) RU2010146701A (pt)
SG (1) SG190570A1 (pt)
WO (1) WO2009130176A1 (pt)
ZA (1) ZA201006647B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201700063T1 (it) * 2009-09-03 2017-03-08 Medimmune Llc Diagnosi di interferoni di tipo 1
NZ599373A (en) * 2009-11-14 2013-04-26 Hoffmann La Roche Biomarkers for predicting rapid response to hcv treatment
WO2011132086A2 (en) 2010-04-21 2011-10-27 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN103740755A (zh) * 2013-12-23 2014-04-23 中国农业大学 猪ifit1基因在抗prrs病毒中的应用
RU2730836C2 (ru) 2014-08-14 2020-08-26 Мемед Диагностикс Лтд. Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
EP3230740B1 (en) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
WO2017149547A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20080161203A1 (en) * 2006-12-27 2008-07-03 Su Chun-Lin Markers identified for liver fibrosis and cirrhosis and the microarray panel thereof

Also Published As

Publication number Publication date
RU2010146701A (ru) 2012-05-27
ZA201006647B (en) 2011-05-25
SG190570A1 (en) 2013-06-28
EP2271776A1 (en) 2011-01-12
WO2009130176A1 (en) 2009-10-29
US20110117563A1 (en) 2011-05-19
MA32274B1 (fr) 2011-05-02
CN102016072A (zh) 2011-04-13
WO2009130176A9 (en) 2010-01-07
AU2009240021A1 (en) 2009-10-29
KR20110014979A (ko) 2011-02-14
NZ588144A (en) 2012-04-27
AU2009240021B2 (en) 2013-01-10
MX2010011587A (es) 2011-05-03
JP2011519551A (ja) 2011-07-14
IL208351A0 (en) 2010-12-30
CA2719078A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
LTC2932970I2 (lt) Antivirusinė terapija
FIC20170031I1 (fi) alirokumabi
SMT201600351B (it) Composti antivirali
PL2280973T3 (pl) Analogi karba-nukleozydowe do leczenia przeciwwirusowego
BRPI0916931A2 (pt) agentes terapêuticos
EP2296593A4 (en) MEDICAL HEAD COVER
IL207826A0 (en) Antiviral therapeutic agents
BRPI0907376A2 (pt) Fotobiorretador
BRPI0906366A2 (pt) Inalador
BRPI0914817A2 (pt) inalador
ZA201006647B (en) Antiviral therapy
BRPI0906779A2 (pt) Inalador
BRPI0907522A2 (pt) biarlamidas
LT3150178T (lt) Stimuliavimo aparatas
BRPI0920743A2 (pt) ribonucleases terapeuticas
BRPI0906367A2 (pt) inalador
BRPI0818598A2 (pt) agentes terapêuticos - 802
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0906369A2 (pt) Inalador
EP2138172A4 (en) ANTIVIRAL ACTIVE SUBSTANCE
PL2090199T3 (pl) Tułów
EP2309854A4 (en) ACCELERATED THERAPY:
BRPI0909764A2 (pt) compostos terapêuticos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.